Skip to main content
. 2024 Oct 4;29(6):697–708. doi: 10.1016/j.cstres.2024.10.001

Fig. 2.

Fig. 2

The expression of Keap1 and Nrf2 in BEAS-2B cells after being exposed to CSE for 24 h with ebeiedinone and peimisine (1, 10, 40, and 80 μM) treated. (a) and (d) Protein expressions of Keap1 and Nrf2 by western blot assay. (b) and (e) The quantified expression of Keap1/GAPDH. (c) and (f) The quantified expression of Nrf2/GAPDH. The data are represented as the mean ± standard deviation of three independent experiments. #P < 0.05, ###P < 0.001, and ####P < 0.0001 compared with the control group. **P < 0.01, ***P < 0.001, and ****P < 0.0001 compared with the CSE group. Abbreviation used: ns, not significant.